GPCR Antitarget Modeling: Pharmacophore Models for Biogenic Amine Binding GPCRs to Avoid GPCR‐Mediated Side Effects
- 22 April 2005
- journal article
- Published by Wiley in ChemBioChem
- Vol. 6 (5) , 876-889
- https://doi.org/10.1002/cbic.200400369
Abstract
G protein‐coupled receptors (GPCRs) form a large protein family that plays an important role in many physiological and pathophysiological processes. However, the central role that the biogenic amine binding GPCRs and their ligands play in cell signaling poses a risk in new drug candidates that reveal side affinities towards these receptor sites. These candidates have the potential to interfere with the physiological signaling processes and to cause undesired effects in preclinical or clinical studies. Here, we present 3D cross‐chemotype pharmacophore models for three biogenic amine antitargets: the α1Aadrenergic, the 5‐HT2Aserotonin, and the D2 dopamine receptors. These pharmacophores describe the key chemical features present within these biogenic amine antagonists and rationalize the biogenic amine side affinities found for numerous new drug candidates. First applications of the α1Aadrenergic receptor model reveal that these in silico tools can be used to guide the chemical optimization towards development candidates with fewer α1A‐mediated side effects (for example, orthostatic hypotension) and, thus, with an improved clinical safety profile.Keywords
This publication has 37 references indexed in Scilit:
- Structure-based Drug Discovery Using GPCR Homology Modeling: Successful Virtual Screening for Antagonists of the Alpha1A Adrenergic ReceptorJournal of Medicinal Chemistry, 2005
- Ligand‐Binding Modes in Cationic Biogenic Amine ReceptorsChemBioChem, 2004
- Chemogenomics knowledge-based strategies in drug discoveryDrug News & Perspectives, 2003
- Drug Design Strategies for Targeting G-Protein-Coupled ReceptorsChemBioChem, 2002
- The Binding Site of Aminergic G Protein–Coupled Receptors: The Transmembrane Segments and Second Extracellular LoopAnnual Review of Pharmacology and Toxicology, 2002
- A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor.Journal of Computer-Aided Molecular Design, 2002
- Synthesis, Biological Evaluation, and Pharmacophore Generation of New Pyridazinone Derivatives with Affinity toward α1- and α2-AdrenoceptorsJournal of Medicinal Chemistry, 2001
- Ligand Design for Alpha1 AdrenoceptorsCurrent Medicinal Chemistry, 2001
- Identification of Critical Determinants of α1-Adrenergic Receptor Subtype Selective Agonist BindingPublished by Elsevier ,1995
- Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brainNeuropharmacology, 1977